Please login to the form below
Diovan/Co-Diovan
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.
It’s only money
It is suspected that falsified data was used in the clinical trial of Novartis’s best selling drug Diovan.
Novartis sales dip, but all eyes are on Entresto
pressure drug Diovan (valsartan) and other products such as its oestrogen patch Vivelle-Dot.
Novartis heart drug may see novel pricing plan
The drug, which combines its now off patent blood pressure drug Diovan (valsartan) and a new antihypertensive drug sacubitril, is set for approval in August for patients with heart failure.
Heart drug sales continue downward spiral
Novartis has been one of the hardest hit in recent years with the patent losses of its blood pressure drug Diovan (valsartan), which was making $6bn in sales a year at
Novartis still hungry after absorbing GSK oncology
The company is now starting to recover from patent expirations on former top brands such as Diovan (valsartan) for high blood pressure and combination follow-up Exforge (valsartan and amlodipine), with
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
